Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKZWR
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,486
Award facts
- Contract value 100% obligated
- $16,485.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, a delivery order valued at $16,485.94 for STELARA 90 mg/mL syringes. This firm fixed-price delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a continuation of Dakota Drug's role as a critical pharmaceutical supplier to U.S. military medical operations. The award carries no set-aside designation and will be performed at Dakota Drug's Anoka, Minnesota facility.
This delivery order falls under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and extending through December 31, 2025. The underlying IDC supports the Defense Logistics Agency's mission to supply pharmaceutical products, medical supplies, and healthcare equipment to U.S. Armed Forces medical facilities. Stelara, a biologic immunosuppressant medication used to treat various inflammatory conditions, represents one of many critical pharmaceutical products Dakota Drug delivers to military healthcare facilities, alongside medications for diabetes management, respiratory conditions, and other therapeutic categories essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FKZWR?
SPE2DB25FKZWR was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FKZWR worth?
The government has obligated $16,486 on SPE2DB25FKZWR.
Is contract SPE2DB25FKZWR an order under another contract?
Yes. SPE2DB25FKZWR is a delivery order under SPE2DB24D8001, an indefinite delivery contract.
Was contract SPE2DB25FKZWR competed?
The extent of competition for SPE2DB25FKZWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award